SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

Published July 2, 2026 · Category: Finance

Overview

Investors seeking broad, low-cost healthcare exposure may prefer State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV), while iShares Biotechnology ETF (NASDAQ:IBB) caters to those specifically targeting the high-growth biotechnology subsector.

Both funds provide exposure to the healthcare space, but they operate with different investment scopes. Selecting between them requires weighing the growth potential of advanced therapies against the stability of diversified medical giants. XLV tracks the Health Care Select Sector Index, encompassing pharmaceutical giants and service providers within the S&P 500.

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

• I’m a 35-year-old American living in Japan. How can I build long-term wealth without a 401(k) or Roth IRA?
• Most prediction market contracts have low volume, leaving users exposed to volatility and bots
• High-end camping and a capital raise: AutoCamp is banking on summer travel to fuel growth